BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 18589179)

  • 21. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
    Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
    J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic effects of mycophenolate mofetil and sirolimus in prevention of acute heart, pancreas, and kidney allograft rejection and in reversal of ongoing heart allograft rejection in the rat.
    Vu MD; Qi S; Xu D; Wu J; Peng J; Daloze P; Sehgal S; Leduc B; Chen H
    Transplantation; 1998 Dec; 66(12):1575-80. PubMed ID: 9884242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beneficial effect of graft perfusion with anti-T cell receptor monoclonal antibodies on survival of small bowel allografts in rat recipients treated with brequinar alone or in combination with cyclosporine and sirolimus.
    Wang M; Qu X; Stepkowski SM; Chou TC; Kahan BD
    Transplantation; 1996 Feb; 61(3):458-64. PubMed ID: 8610361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mixed allogeneic chimerism as a reliable model for composite tissue allograft tolerance induction across major and minor histocompatibility barriers.
    Foster RD; Ascher NL; McCalmont TH; Neipp M; Anthony JP; Mathes SJ
    Transplantation; 2001 Sep; 72(5):791-7. PubMed ID: 11571439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of transient treatment with FK506 in the early phase on cyclophosphamide-induced bone marrow chimerism and transplant tolerance across MHC barriers.
    Okayama J; Ko S; Kanehiro H; Kanokogi H; Nakajima Y
    J Surg Res; 2006 Jun; 133(2):61-8. PubMed ID: 16376943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feasibility of immunosuppression in composite tissue allografts by systemic administration of CTLA4Ig.
    Iwasaki N; Gohda T; Yoshioka C; Murakami M; Inobe M; Minami A; Uede T
    Transplantation; 2002 Feb; 73(3):334-40. PubMed ID: 11884927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of stable chimerism and transplantation tolerance to rat islet and heart allografts by ultraviolet-B modulation of bone marrow cells.
    Jin MX; Engelstad K; Oluwole SF
    Transplantation; 1992 Jul; 54(1):113-8. PubMed ID: 1385914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A partial conditioning strategy for achieving mixed chimerism in the rat: tacrolimus and anti-lymphocyte serum substantially reduce the minimum radiation dose for engraftment.
    Gammie JS; Li S; Colson YL; Demetris AJ; Neipp M; Ildstad ST; Pham SM
    Exp Hematol; 1998 Sep; 26(10):927-35. PubMed ID: 9728927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A clinically relevant CTLA4-Ig-based regimen induces chimerism and tolerance to heart grafts.
    Li S; Thanikachalam M; Pang M; Kawaharada N; Aitouche A; Pham SM
    Ann Thorac Surg; 2001 Oct; 72(4):1306-10. PubMed ID: 11603451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimizing chimerism level through bone marrow transplantation and irradiation to induce long-term tolerance to composite tissue allotransplantation.
    Lin JY; Tsai FC; Wallace CG; Huang WC; Wei FC; Liao SK
    J Surg Res; 2012 Nov; 178(1):487-93. PubMed ID: 22484382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The combination of mitomycin-induced blood cells with a temporary treatment of ciclosporin A prolongs allograft survival in vascularized composite allotransplantation.
    Radu CA; Fischer S; Diehm Y; Hetzel O; Neubrech F; Dittmar L; Kleist C; Gebhard MM; Terness P; Kneser U; Kiefer J
    Langenbecks Arch Surg; 2018 Feb; 403(1):83-92. PubMed ID: 28823033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term survival of limb allografts induced by pharmacologically conditioned, donor alloantigen-pulsed dendritic cells without maintenance immunosuppression.
    Ikeguchi R; Sacks JM; Unadkat JV; Solari M; Horibe EK; Thomson AW; Lee AW; Feili-Hariri M
    Transplantation; 2008 Jan; 85(2):237-46. PubMed ID: 18212629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-dose immunosuppression in a rat hind-limb transplantation model.
    Perez-Abadia G; Laurentin-Perez L; Gorantla VS; Francois CG; Vossen M; Brouha PC; Orhun HI; Anderson GL; Maldonado C; Pidwell DJ; Breidenbach WC; Barker JH
    Transpl Int; 2003 Dec; 16(12):835-42. PubMed ID: 12904844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naïve-donor-strain bone-marrow cells.
    Nakao A; Nalesnik MA; Ishikawa T; Azhipa O; Demetris AJ; Murase N
    Transplantation; 2003 May; 75(9):1575-81. PubMed ID: 12792518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. UV-B modulation of haplo-identical bone marrow cells in the prevention of GVHD and induction of specific transplantation tolerance to intestinal allografts.
    Chowdhury NC; Jin MX; Hardy MA; Oluwole SF
    Transpl Immunol; 1994 Dec; 2(4):331-6. PubMed ID: 7704543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of an improved sirolimus (rapamycin)-based regimen for induction of allograft tolerance in mice treated with antilymphocyte serum and donor-specific bone marrow.
    Hale DA; Gottschalk R; Maki T; Monaco AP
    Transplantation; 1998 Feb; 65(4):473-9. PubMed ID: 9500619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental limb transplantation, part III: induction of tolerance in the rigorous strain combination of Brown Norway donor to Lewis recipient.
    Kanatani T; Wright B; Lanzetta M; Molitor M; McCaughan GW; Bishop GA
    Transplant Proc; 2004 Dec; 36(10):3276-82. PubMed ID: 15686745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of tolerance toward rat cardiac allografts by treatment with allochimeric class I MHC antigen and FTY720.
    Chueh SC; Tian L; Wang M; Wang ME; Stepkowski SM; Kahan BD
    Transplantation; 1997 Nov; 64(10):1407-14. PubMed ID: 9392303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of rapamycin and FK 506 in prolonging rat hind limb allograft survival.
    Fealy MJ; Umansky WS; Bickel KD; Nino JJ; Morris RE; Press BH
    Ann Surg; 1994 Jan; 219(1):88-93. PubMed ID: 7507657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.